The National Medal of Technology and Innovation (NMTI) is now accepting nominations for 2018. Awarded by the President of the United States, the NMTI is the nation’s highest honor for technological achievement. If you know of an individual, team, or company that has made an outstanding technological contribution to United States’ economic, environmental, or social well-being, you can submit nominations until the April 6 deadline. The nomination form, a sample recommendation letter, and FAQs are available on the NMTI website.Continue reading
Author Archive: AZBio
Destroy Pancreatic Cancer dedicates $1 million for unique TGen-designed clinical trial
Destroy Pancreatic Cancer, an Atlanta-based non-profit dedicated to finding better treatments for the most deadly of all cancers, is donating $1 million for a unique pancreatic cancer clinical trial designed by the non-profit Translational Genomics Research Institute (TGen).Continue reading
Focus On Lyme Foundation Builds Biorepository Consisting of Chronic Lyme Disease and Post-Treatment Lyme Disease Syndrome (PTLDS) Donors
When Focus on Lyme put out the call for volunteers willing to donate blood samples for research on Lyme disease, the entire day’s schedule was filled within minutes. Some participants, many quite ill, traveled hundreds of miles just to make a blood donation.Continue reading
Learn what’s next at Flinn
In the Flinn Foundation’s new report, President and CEO Tammy McLeod looks ahead at how the Foundation’s programs can make a difference across Arizona. Continue reading
RightBio Metrics Wins A First Place Patient Safety Innovation Award for the RightSpot®
RightBio Metrics was recently honored with a first place Patient Safety Innovation Award. Award recipients were announced on February 23rd in London, England during the 6th Annual World Patient Safety, Science & Technology Summit. The Patient Safety Movement Foundation (https://patientsafetymovement.org) received 55 submissions from 6 countries and awarded RightBio Metrics first place based on the RightSpot’s ability to help improve patient safety.
Jason Field to Succeed Terri Kelly as President and CEO of W. L. Gore & Associates
Terri Kelly to retire from Gore after 35 years. Jason Field to serve as President and CEO effective April 1, 2018
INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms
Pivotal study aims to evaluate safety and efficacy of company’s novel CBD product candidate in rare type of pediatric epilepsyContinue reading
TGen-led Study Finds Potent Anti-Cancer Drug Effect in Rare Ovarian Cancer
Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months